医薬品ネイティブスターチの世界市場レポート 2025年

医薬品ネイティブスターチの市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR8.9％で86億9,000万米ドルに成長します。予測期間に予想される成長の原動力は、医薬品イノベーションへの投資の増加、持続可能な調達への注力の強化、新規製剤の使用の増加、クリーンラベル医薬品への需要の増加、新興市場におけるヘルスケア支出の増加です。予測期間における主な動向としては、デンプン加工技術の進歩、ドラッグデリバリーシステムの革新、バイオベースの医薬品原料の開発、植物由来の賦形剤の研究開発、溶解性と安定性ソリューションの進歩などが挙げられます。

慢性疾患の有病率の増加は、今後数年間における医薬品用化工デンプン市場の拡大を促進すると予想されます。慢性疾患は、一般的に徐々に発症し、1年以上続く長期的な病状です。慢性疾患の増加は人口の高齢化が主な原因であり、高齢者は糖尿病、心血管疾患、関節炎、がんなどの長期的な健康問題に罹患しやすく、これらは加齢とともに流行しやすくなるからです。医薬品原料でんぷんは、薬剤製剤の安定性を高め、バイオアベイラビリティを向上させ、薬剤放出の制御を可能にし、患者のアドヒアランスを促進し、最終的には慢性疾患の有効性と長期管理をサポートすることにより、慢性疾患の管理において重要な役割を果たしています。例えば、2024年6月、オーストラリア保健福祉研究所は、慢性疾患による死亡率が増加し、2021年の人口10万人当たり459人から2022年には490人に増加すると報告しました。その結果、慢性疾患の有病率の増加が、医薬品原料でんぷん市場の成長を後押ししています。

医薬品用生デンプン市場の企業は、製剤化と患者のコンプライアンスを改善するため、植物性テクスチャーなどの革新的製品の開発に注力しています。植物由来のテクスチャーとは、厚みやゲル強度などの植物由来成分の物理的特性を指し、より効果的な天然薬物製剤のために錠剤の結合性、崩壊性、口当たりを改善することで、医薬品における生デンプンの性能を高めるのに役立ちます。例えば、2024年2月、米国の食品会社であるIngredion Incorporatedは、乳製品および代替乳製品のテクスチャーと安定性を改善するために設計されたクリーンラベルのテクスチャライザーであるNovation Indulge 2940デンプンを発売しました。この革新的な医薬品原料でんぷんは、医薬品製剤の性能、生物学的利用能、放出制御を向上させる機能的利点を提供し、同時にクリーンラベルで持続可能な製品の開発をサポートします。NOVATION Indulge 2940澱粉は、クリーンラベルの天然原料を使用し、乳製品および代替乳製品の食感、安定性、消費者の受容性を改善します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、貿易戦争と関税、そしてコロナ禍と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の医薬品ネイティブスターチPESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の医薬品ネイティブスターチ市場：成長率分析
• 世界の医薬品ネイティブスターチ市場の実績：規模と成長, 2019-2024
• 世界の医薬品ネイティブスターチ市場の予測：規模と成長, 2024-2029, 2034F
• 世界の医薬品ネイティブスターチ総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の医薬品ネイティブスターチ市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ジャガイモ澱粉
• コーンスターチ
• その他のタイプ
• 世界の医薬品ネイティブスターチ市場：剤形タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 経口固形剤
• 液体剤形
• 局所製剤
• 注射薬
• 制御放出製剤
• 世界の医薬品ネイティブスターチ市場：機能別、実績と予測, 2019-2024, 2024-2029F, 2034F
• テクスチャリング剤
• 保湿剤
• 増量剤
• 乳化剤
• フィルム形成剤
• 世界の医薬品ネイティブスターチ市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• バインダーとコーティング剤
• 崩壊剤
• 充填剤と増量剤
• 安定剤
• 増粘剤
• 世界の医薬品ネイティブスターチ市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 製薬メーカー
• 受託研究機関（Cros）
• 受託製造組織（CMOS）
• 研究開発ラボ
• 学術機関
• その他のエンドユーザー
• 世界の医薬品ネイティブスターチ市場、ジャガイモ澱粉のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 加工ジャガイモ澱粉
• 天然ジャガイモ澱粉
• 世界の医薬品ネイティブスターチ市場、コーンスターチのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 加工コーンスターチ
• 天然コーンスターチ
• 世界の医薬品ネイティブスターチ市場、その他のタイプのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 米澱粉
• 小麦澱粉
• タピオカ澱粉

第7章 地域別・国別分析

• 世界の医薬品ネイティブスターチ市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の医薬品ネイティブスターチ市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 医薬品ネイティブスターチ市場：競合情勢
• 医薬品ネイティブスターチ市場：企業プロファイル
  • Cargill Incorporated Overview, Products and Services, Strategy and Financial Analysis
  • Archer Daniels Midland Company Overview, Products and Services, Strategy and Financial Analysis
  • Ingredion Incorporated Overview, Products and Services, Strategy and Financial Analysis
  • Tereos SCA Overview, Products and Services, Strategy and Financial Analysis
  • Roquette Freres SA. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• AGRANA
• Tate & Lyle Public Limited Company
• Colorcon Inc.
• Grain Processing Corporation
• Siam Modified Starch Co. Ltd.
• BENEO GmbH
• Gulshan Polyols Ltd.
• SPAC Starch Products（India）Private Limited
• Universal Starch-Chem Allied Ltd.
• Sanstar Biopolymers Ltd.
• Emsland Group
• Hungrana Kft.
• Bluecraft Agro Pvt. Ltd.
• Visco Starch
• Shandong Liujia Pharmaceutical Excipient Co.Ltd.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 医薬品ネイティブスターチ市場2029：新たな機会を提供する国
• 医薬品ネイティブスターチ市場2029：新たな機会を提供するセグメント
• 医薬品ネイティブスターチ市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Pharmaceutical native starch is a natural, unmodified starch sourced from plants such as corn, potato, wheat, or tapioca, and is used as an excipient in pharmaceutical formulations. It serves various purposes such as acting as a binder, disintegrant, or filler in tablets and capsules, playing a key role in regulating medication release, enhancing stability, and ensuring proper tablet formation, all without the need for chemical or physical alteration.

The primary types of pharmaceutical native starches include potato starch, corn starch, and others. Potato starch, a fine white powder extracted from potato tubers, is recognized for its smooth texture and superior binding capabilities, making it well-suited for pharmaceutical tablet formulations. It is available in various formulation types, including oral solids, liquids, topical products, injectables, and controlled-release formulations. Its versatility allows it to function as a texturizer, moisture-retaining agent, bulking agent, emulsifier, and film-former. It is commonly used as a binder, coating agent, disintegrant, filler, stabilizer, and thickener, serving a wide range of end-users such as pharmaceutical manufacturers, contract research organizations (CROs), contract manufacturing organizations (CMOs), research and development labs, academic institutions, and more.

The pharmaceuticals native starch market research report is one of a series of new reports from The Business Research Company that provides pharmaceuticals native starch market statistics, including pharmaceuticals native starch industry global market size, regional shares, competitors with a pharmaceuticals native starch market share, pharmaceuticals native starch market segments, market trends, and opportunities, and any further data you may need to thrive in the pharmaceuticals native starch industry. This pharmaceuticals native starch market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The pharmaceuticals native starch market size has grown strongly in recent years. It will grow from $5.65 billion in 2024 to $6.17 billion in 2025 at a compound annual growth rate (CAGR) of 9.1%. The growth observed in the past can be linked to a higher demand for natural excipients, increased pharmaceutical production, a growing preference for biocompatible ingredients, the expansion of generic drug manufacturing, and greater regulatory backing for natural ingredients.

The pharmaceuticals native starch market size is expected to see strong growth in the next few years. It will grow to $8.69 billion in 2029 at a compound annual growth rate (CAGR) of 8.9%. The growth expected in the forecast period is driven by rising investments in pharmaceutical innovation, a stronger focus on sustainable sourcing, the growing use of novel drug formulations, an increasing demand for clean-label pharmaceutical products, and higher healthcare spending in emerging markets. Key trends in the forecast period include advancements in starch processing technology, innovations in drug delivery systems, developments in bio-based pharmaceutical ingredients, ongoing research in plant-based excipients, and progress in solubility and stability solutions.

The growing prevalence of chronic diseases is expected to drive the expansion of the pharmaceutical native starch market in the coming years. Chronic diseases are long-term medical conditions that typically develop gradually and last for over a year. The rise in chronic diseases is largely due to an aging population, as older individuals are more prone to long-term health issues such as diabetes, cardiovascular diseases, arthritis, and cancer, which become more prevalent with age. Pharmaceutical native starch plays a significant role in managing chronic diseases by enhancing the stability of drug formulations, improving bioavailability, enabling controlled drug release, promoting patient adherence, and ultimately supporting the effectiveness and long-term management of chronic conditions. For example, in June 2024, the Australian Institute of Health and Welfare reported an increase in the death rate from chronic diseases, rising from 459 per 100,000 people in 2021 to 490 per 100,000 in 2022. As a result, the growing prevalence of chronic diseases is fueling the growth of the pharmaceutical native starch market.

Companies in the pharmaceutical native starch market are focusing on developing innovative products, such as plant-based textures, to improve drug formulation and patient compliance. Plant-based textures refer to the physical properties of plant-derived ingredients, such as thickness and gel strength, which help enhance the performance of native starch in pharmaceuticals by improving tablet binding, disintegration, and mouthfeel for more effective natural drug formulations. For example, in February 2024, Ingredion Incorporated, a U.S.-based food company, launched Novation Indulge 2940 starch, a clean-label texturizer designed to improve texture and stability in dairy and alternative dairy products. This innovative pharmaceutical native starch offers functional benefits that enhance drug formulation performance, bioavailability, and controlled release, while supporting the development of clean-label, sustainable products. NOVATION Indulge 2940 starch improves texture, stability, and consumer acceptance in both dairy and alternative dairy products, using clean-label, natural ingredients.

In September 2022, Roquette Freres, a France-based food company, acquired Crest Cellulose for an undisclosed sum. This acquisition aims to strengthen Roquette's position in the pharmaceutical excipients market by expanding its range of plant-based, pharmacopoeia-compliant solutions and meeting the growing demand for high-quality drug delivery ingredients, particularly in India and the Asia Pacific region. Crest Cellulose, an India-based manufacturer, specializes in producing pregelatinized starch and sodium starch glycolate.

Major players in the pharmaceuticals native starch market are Cargill Incorporated, Archer Daniels Midland Company, Ingredion Incorporated, Tereos SCA, Roquette Freres SA., AGRANA, Tate & Lyle Public Limited Company, Colorcon Inc., Grain Processing Corporation, Siam Modified Starch Co. Ltd., BENEO GmbH, Gulshan Polyols Ltd., SPAC Starch Products (India) Private Limited, Universal Starch-Chem Allied Ltd., Sanstar Biopolymers Ltd., Emsland Group, Hungrana Kft., Bluecraft Agro Pvt. Ltd., Visco Starch, and Shandong Liujia Pharmaceutical Excipient Co.Ltd.

North America was the largest region in the pharmaceuticals native starch market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in pharmaceuticals native starch report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the pharmaceuticals native starch market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pharmaceuticals native starch market consists of sales of sorghum starch, barley starch, sweet potato starch, and arrowroot starch. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pharmaceuticals Native Starch Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pharmaceuticals native starch market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pharmaceuticals native starch ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The pharmaceuticals native starch market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Potato Starch; Corn Starch; Other Types
• 2) By Formulation Type: Oral Solid Dosage Forms; Liquid Dosage Forms; Topical Formulations; Injectable Drugs; Controlled Release Formulations
• 3) By Functionality: Texturizing Agent; Moisture Retention Agent; Bulking Agent; Emulsifying Agent; Film-Forming Agent
• 4) By Application: Binders And Coating Agents; Disintegrants; Fillers And Extenders; Stabilizers; Thickening Agents
• 5) By End-User: Pharmaceutical Manufacturers; Contract Research Organizations (CROs); Contract Manufacturing Organizations (CMOs); Research And Development Labs; Academic Institutions; Other End-users
• Subsegments:
• 1) By Potato Starch: Modified Potato Starch; Native Potato Starch
• 2) By Corn Starch: Modified Corn Starch; Native Corn Starch
• 3) By Other Types: Rice Starch; Wheat Starch; Tapioca Starch
• Companies Mentioned: Cargill Incorporated; Archer Daniels Midland Company; Ingredion Incorporated; Tereos SCA; Roquette Freres SA.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Pharmaceuticals Native Starch Market Characteristics

3. Pharmaceuticals Native Starch Market Trends And Strategies

4. Pharmaceuticals Native Starch Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Pharmaceuticals Native Starch Growth Analysis And Strategic Analysis Framework

• 5.1. Global Pharmaceuticals Native Starch PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Pharmaceuticals Native Starch Market Growth Rate Analysis
• 5.4. Global Pharmaceuticals Native Starch Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Pharmaceuticals Native Starch Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Pharmaceuticals Native Starch Total Addressable Market (TAM)

6. Pharmaceuticals Native Starch Market Segmentation

• 6.1. Global Pharmaceuticals Native Starch Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Potato Starch
• Corn Starch
• Other Types
• 6.2. Global Pharmaceuticals Native Starch Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral Solid Dosage Forms
• Liquid Dosage Forms
• Topical Formulations
• Injectable Drugs
• Controlled Release Formulations
• 6.3. Global Pharmaceuticals Native Starch Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Texturizing Agent
• Moisture Retention Agent
• Bulking Agent
• Emulsifying Agent
• Film-Forming Agent
• 6.4. Global Pharmaceuticals Native Starch Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Binders And Coating Agents
• Disintegrants
• Fillers And Extenders
• Stabilizers
• Thickening Agents
• 6.5. Global Pharmaceuticals Native Starch Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pharmaceutical Manufacturers
• Contract Research Organizations (Cros)
• Contract Manufacturing Organizations (Cmos)
• Research And Development Labs
• Academic Institutions
• Other End-Users
• 6.6. Global Pharmaceuticals Native Starch Market, Sub-Segmentation Of Potato Starch, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Modified Potato Starch
• Native Potato Starch
• 6.7. Global Pharmaceuticals Native Starch Market, Sub-Segmentation Of Corn Starch, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Modified Corn Starch
• Native Corn Starch
• 6.8. Global Pharmaceuticals Native Starch Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Rice Starch
• Wheat Starch
• Tapioca Starch

7. Pharmaceuticals Native Starch Market Regional And Country Analysis

• 7.1. Global Pharmaceuticals Native Starch Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Pharmaceuticals Native Starch Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Pharmaceuticals Native Starch Market

• 8.1. Asia-Pacific Pharmaceuticals Native Starch Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Pharmaceuticals Native Starch Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Pharmaceuticals Native Starch Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Pharmaceuticals Native Starch Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Pharmaceuticals Native Starch Market

• 9.1. China Pharmaceuticals Native Starch Market Overview
• 9.2. China Pharmaceuticals Native Starch Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Pharmaceuticals Native Starch Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Pharmaceuticals Native Starch Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Pharmaceuticals Native Starch Market

• 10.1. India Pharmaceuticals Native Starch Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Pharmaceuticals Native Starch Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Pharmaceuticals Native Starch Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Pharmaceuticals Native Starch Market

• 11.1. Japan Pharmaceuticals Native Starch Market Overview
• 11.2. Japan Pharmaceuticals Native Starch Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Pharmaceuticals Native Starch Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Pharmaceuticals Native Starch Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Pharmaceuticals Native Starch Market

• 12.1. Australia Pharmaceuticals Native Starch Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Pharmaceuticals Native Starch Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Pharmaceuticals Native Starch Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Pharmaceuticals Native Starch Market

• 13.1. Indonesia Pharmaceuticals Native Starch Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Pharmaceuticals Native Starch Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Pharmaceuticals Native Starch Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Pharmaceuticals Native Starch Market

• 14.1. South Korea Pharmaceuticals Native Starch Market Overview
• 14.2. South Korea Pharmaceuticals Native Starch Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Pharmaceuticals Native Starch Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Pharmaceuticals Native Starch Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Pharmaceuticals Native Starch Market

• 15.1. Western Europe Pharmaceuticals Native Starch Market Overview
• 15.2. Western Europe Pharmaceuticals Native Starch Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Pharmaceuticals Native Starch Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Pharmaceuticals Native Starch Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Pharmaceuticals Native Starch Market

• 16.1. UK Pharmaceuticals Native Starch Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Pharmaceuticals Native Starch Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Pharmaceuticals Native Starch Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Pharmaceuticals Native Starch Market

• 17.1. Germany Pharmaceuticals Native Starch Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Pharmaceuticals Native Starch Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Pharmaceuticals Native Starch Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Pharmaceuticals Native Starch Market

• 18.1. France Pharmaceuticals Native Starch Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Pharmaceuticals Native Starch Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Pharmaceuticals Native Starch Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Pharmaceuticals Native Starch Market

• 19.1. Italy Pharmaceuticals Native Starch Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Pharmaceuticals Native Starch Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Pharmaceuticals Native Starch Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Pharmaceuticals Native Starch Market

• 20.1. Spain Pharmaceuticals Native Starch Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Pharmaceuticals Native Starch Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Pharmaceuticals Native Starch Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Pharmaceuticals Native Starch Market

• 21.1. Eastern Europe Pharmaceuticals Native Starch Market Overview
• 21.2. Eastern Europe Pharmaceuticals Native Starch Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Pharmaceuticals Native Starch Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Pharmaceuticals Native Starch Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Pharmaceuticals Native Starch Market

• 22.1. Russia Pharmaceuticals Native Starch Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Pharmaceuticals Native Starch Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Pharmaceuticals Native Starch Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Pharmaceuticals Native Starch Market

• 23.1. North America Pharmaceuticals Native Starch Market Overview
• 23.2. North America Pharmaceuticals Native Starch Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Pharmaceuticals Native Starch Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Pharmaceuticals Native Starch Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Pharmaceuticals Native Starch Market

• 24.1. USA Pharmaceuticals Native Starch Market Overview
• 24.2. USA Pharmaceuticals Native Starch Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Pharmaceuticals Native Starch Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Pharmaceuticals Native Starch Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Pharmaceuticals Native Starch Market

• 25.1. Canada Pharmaceuticals Native Starch Market Overview
• 25.2. Canada Pharmaceuticals Native Starch Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Pharmaceuticals Native Starch Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Pharmaceuticals Native Starch Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Pharmaceuticals Native Starch Market

• 26.1. South America Pharmaceuticals Native Starch Market Overview
• 26.2. South America Pharmaceuticals Native Starch Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Pharmaceuticals Native Starch Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Pharmaceuticals Native Starch Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Pharmaceuticals Native Starch Market

• 27.1. Brazil Pharmaceuticals Native Starch Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Pharmaceuticals Native Starch Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Pharmaceuticals Native Starch Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Pharmaceuticals Native Starch Market

• 28.1. Middle East Pharmaceuticals Native Starch Market Overview
• 28.2. Middle East Pharmaceuticals Native Starch Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Pharmaceuticals Native Starch Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Pharmaceuticals Native Starch Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Pharmaceuticals Native Starch Market

• 29.1. Africa Pharmaceuticals Native Starch Market Overview
• 29.2. Africa Pharmaceuticals Native Starch Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Pharmaceuticals Native Starch Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Pharmaceuticals Native Starch Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Pharmaceuticals Native Starch Market Competitive Landscape And Company Profiles

• 30.1. Pharmaceuticals Native Starch Market Competitive Landscape
• 30.2. Pharmaceuticals Native Starch Market Company Profiles
  • 30.2.1. Cargill Incorporated Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Archer Daniels Midland Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Ingredion Incorporated Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Tereos SCA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Roquette Freres SA. Overview, Products and Services, Strategy and Financial Analysis

31. Pharmaceuticals Native Starch Market Other Major And Innovative Companies

• 31.1. AGRANA
• 31.2. Tate & Lyle Public Limited Company
• 31.3. Colorcon Inc.
• 31.4. Grain Processing Corporation
• 31.5. Siam Modified Starch Co. Ltd.
• 31.6. BENEO GmbH
• 31.7. Gulshan Polyols Ltd.
• 31.8. SPAC Starch Products (India) Private Limited
• 31.9. Universal Starch-Chem Allied Ltd.
• 31.10. Sanstar Biopolymers Ltd.
• 31.11. Emsland Group
• 31.12. Hungrana Kft.
• 31.13. Bluecraft Agro Pvt. Ltd.
• 31.14. Visco Starch
• 31.15. Shandong Liujia Pharmaceutical Excipient Co.Ltd.

32. Global Pharmaceuticals Native Starch Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Pharmaceuticals Native Starch Market

34. Recent Developments In The Pharmaceuticals Native Starch Market

35. Pharmaceuticals Native Starch Market High Potential Countries, Segments and Strategies

• 35.1 Pharmaceuticals Native Starch Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Pharmaceuticals Native Starch Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Pharmaceuticals Native Starch Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer